Radiology, Vol 193, 71-74, Copyright © 1994 by Radiological Society of North America

ARTICLES

Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography

P Soyer, DA Bluemke, RH Hruban, JV Sitzmann and EK Fishman
Department of Radiology, Johns Hopkins Hospital, Baltimore, Md.

PURPOSE: To determine the sensitivity and false-positive rate of helical computed tomography during arterial portography (CTAP) in the detection of hepatic metastases from colorectal cancer. MATERIALS AND METHODS: Preoperative helical CTAP was performed to examine 23 patients (10 men and 13 women, aged 43-77 years [mean, 63 years]) who later underwent surgical tumor resection. Imaging findings were retrospectively reviewed by two radiologists and were correlated with intraoperative and histologic findings. RESULTS: Helical CTAP demonstrated 33 of 35 metastases, with diameters of 4-95 mm, that were identified in resected specimens (sensitivity, 94%). The two metastases not demonstrated were 4 and 5 mm in diameter. Five false-positive lesions were found in four patients, yielding a false-positive rate of 17% by patient analysis and 13% by lesion analysis. CONCLUSION: The sensitivity of helical CTAP in the preoperative detection of hepatic metastases is high, and its false-positive rate compares favorably with that of conventional CTAP, but future comparative studies are needed to determine which is the better modality.

This article has been cited by other articles:

				W. P. Hosch, S. M. Schmidt, S. Plaza, C. Dechow, J. Schmidt, S. Ley, G. W. Kauffmann, and J. Hansmann Comparison of CT during arterial portography and MR during arterial portography in the detection of liver metastases. Am. J. Roentgenol., June 1, 2006; 186(6): 1502 - 1511. [Abstract] [Full Text] [PDF]

				H. C. Kim, T. K. Kim, K.-B. Sung, H.-K. Yoon, P. N. Kim, H. K. Ha, A. Y. Kim, H. J. Kim, and M.-G. Lee CT during Hepatic Arteriography and Portography: An Illustrative Review RadioGraphics, September 1, 2002; 22(5): 1041 - 1051. [Abstract] [Full Text] [PDF]

				A. R. van Erkel, M. E. J. Pijl, A. A. van den Berg-Huysmans, M. N. J. M. Wasser, C. J. H. van de Velde, and J. L. Bloem Hepatic Metastases in Patients with Colorectal Cancer: Relationship between Size of Metastases, Standard of Reference, and Detection Rates Radiology, August 1, 2002; 224(2): 404 - 409. [Abstract] [Full Text] [PDF]

				G. N. Mann, H. F. Marx, L. L. Lai, and L. D. Wagman Clinical and Cost Effectiveness of a New Hepatocellular MRI Contrast Agent, Mangafodipir Trisodium, in the Preoperative Assessment of Liver Resectability Ann. Surg. Oncol., August 1, 2001; 8(7): 573 - 579. [Abstract] [Full Text] [PDF]

				D. A. Bluemke, E. K. Paulson, M. A. Choti, S. DeSena, and P. A. Clavien Detection of Hepatic Lesions in Candidates for Surgery: Comparison of Ferumoxides-Enhanced MR Imaging and Dual-Phase Helical CT Am. J. Roentgenol., December 1, 2000; 175(6): 1653 - 1658. [Abstract] [Full Text] [PDF]

				G. T. Sica, H. Ji, and P. R. Ros CT and MR Imaging of Hepatic Metastases Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698. [Full Text] [PDF]

				S. S. Yoon and K. K. Tanabe Surgical Treatment and Other Regional Treatments for Colorectal Cancer Liver Metastases Oncologist, June 1, 1999; 4(3): 197 - 208. [Abstract] [Full Text]